Clinical Trial Update: Fluoxetine Versus Fluoxetine Plus DU125530 in Major Depressive Disorder [Phase 2]

View source ↗

Summary

This Phase 2 trial comparing fluoxetine alone to fluoxetine plus DU125530 in major depressive disorder has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• DU125530 (DU125530)
• Fluoxetine (Fluoxetine)

Snippet

Sponsor: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | Conditions: Major Depression | Phase 2 | Status: TERMINATED